About 294,000 U.S. children and teenagers under age 18 (or one in 250 children) have been diagnosed with arthritis or another rheumatologic condition.
Arthritis Pain Treatment
For patients with rheumatoid arthritis, combining one well-known, lower cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness
Researchers carried out a genome-wide association study of nearly 400 individuals with rheumatoid arthritis and identified a novel variant on chromosome 6 that increases the risk for developing the disease.
A team of researchers has discovered two genes linked to a disabling form of arthritis called ankylosing spondylitis.
Life expectancy for rheumatoid arthritis patients has not improved over the past 4 decades.
Work limitation due to arthritis in all working-age adults ranges from a low of 3.4 percent in Hawaii to a high of 15 percent in Kentucky.
Researchers have identified a genetic region associated with increased risk of rheumatoid arthritis (RA).
Health Canada advised the public not to use the health product Asam Urat Flu Tulang, PJ Dewandaru promoted to treat joint pain, rheumatism and arthritis.
Health Canada advised consumers not to use Khun-Phra promoted to treat arthritis and joint pain.
For patients with rheumatoid arthritis under routine medical supervision, an 8-week meditation class plus a 4-month maintenance program had beneficial effects.
Small Bone Innovations's Artelon STT Spacer for early to mid-stage osteo-arthritis has been cleared by the FDA for marketing in the US.
More than 100 rheumatoid arthritis patients suffering from pain in the balls of their feet are to take part in new research at Leeds University.
A genetic variation has been identified that increases the risk of two chronic, autoimmune inflammatory diseases: rheumatoid arthritis (RA) and systemic lupus erythematosus (lupus). These research findings result from a long-time collaboration between the Intramural Research Program (IRP) of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other organizations. NIAMS is part of the National Institutes of Health.
These results appear in the Sept. 6 issue of the New England Journal of Medicine.
More than 1,000 rheumatoid arthritis patients from West Yorkshire are to take part in a major new study which could lead to more effective targeting of treatment.
A panel of arthritis research experts has recommended that coxibs and nonsteroidal anti-inflammatory drugs (NSAIDs) must remain a significant part of the tool kit used in treating osteoarthritis (OA).
Among older people with arthritis, blacks and Hispanics are more likely than whites to be unable to perform at least one daily living activity as a result of the condition.
Results from the AMBITION trial successfully met its primary endpoint of non-inferiority in patients with moderheumatoid arthritiste to severe rheumatoid arthritis.
ZARS commenced the first of two Phase 3 clinical trials of ThermoProfen in patients with mild to moderate osteoarthritis of the knee.
Rheumatoid arthritis affects 2.1 million Americans and despite many advances in the understanding of the disease, funds for research remain limited and both the cause and a cure are still unknown.
Fiskars PowerGear line of garden tools makes gardening so much easier that the Arthritis Foundation has awarded them with the prestigious Ease-of-Use Commendation.
Even though more than two million Americans suffer from it, 40 percent of the nation's population does not realize gout is one of the most painful forms of arthritis.
Arthritis sufferers who undergo psychological counseling and learn skills for coping with pain have less disability and better quality of life.
A new report revealed arthritis prevalence and activity limitations will increase substantially in all but two states and the District of Columbia by 2030.